Ruben van Eijk is an MD and biostatistician at the UMCU, The Netherlands. He was a Visiting Scholar at the Center for Innovative Study Design, Stanford University. His current research focusses on integrating real-world data into clinical trials and developing new endpoints that address multidimensionality and differences in patient preference.
